KIMS Hospitals Announces Investor Presentation for Q2 & Half-Year Ended Sep 30, 2025
KIMS Hospitals announced its investor presentation for Q2 & Half-Year Ended September 30, 2025. Consolidated Q2 FY26 total revenue was ₹96.49 crore, a growth of 23.3% YoY. PAT stood at ₹7.20 crore.
The announcement provides information about the financial performance and future plans, which could have a moderate impact on investors.
The announcement is a routine update regarding the investor presentation and financial results. While there is revenue growth, there is also a decrease in EBITDA and PAT, balancing the sentiment.
* KIMS Hospitals announced the investor presentation on unaudited (Standalone & Consolidated) financial results for the second quarter and half-year ended 30 September 2025. * The presentation is available on the company's website under the Investor Relations section. * Consolidated Q2 FY26 total revenue was ₹96.49 crore, a growth of 23.3% YoY and 9.8% QoQ. * EBITDA was ₹20.82 crore, a degrowth of 6.7% YoY and a growth of 4.3% QoQ. EBITDA margin was 21.6% compared to 28.5% in Q2 FY25. * PAT stood at ₹7.20 crore, compared to ₹12.07 crore in Q2 FY25. * The Company has planned to add 2100+ beds through green field projects and O&M opportunities. * The new 361-bed KIMS PES facility is scheduled to commence phased operations starting in November 2025.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.